Sawai Group Holdings Co., Ltd. (TYO: 4887)

Market Cap	263.64B
Revenue (ttm)	168.20B
Net Income (ttm)	25.66B
Shares Out	42.90M
EPS (ttm)	480.88
PE Ratio	20.43
Forward PE	9.64
Dividend	159.00 (2.61%)
Ex-Dividend Date	Sep 27, 2024

Volume	206,200
Open	6,010.00
Previous Close	6,095.00
Day's Range	5,965.00 - 6,162.00
52-Week Range	4,297.00 - 6,926.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2024

About Sawai Group Holdings

Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals. The company offers generic drugs in various dosage forms, including tablets, oral dispersing tablets, capsules, granules, injectables, tapes, ophthalmic or nasal solutions, syrups, and other forms for various therapeutic areas comprising cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, anti-cancer, urogenital organs a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 3,482
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4887

Financial Performance

In 2023, Sawai Group Holdings's revenue was 176.86 billion, a decrease of -11.72% compared to the previous year's 200.34 billion. Earnings were 13.70 billion, an increase of 8.12%.